...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
【24h】

Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.

机译:取代的2,N-苄基羧酰胺基-5-(2-乙基-1-二氧代咪唑啉基)-N,N-二甲基色胺衍生物的合成和血清素能活性:血管5-HT(1B)-样受体的新型拮抗剂。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The synthesis and vascular 5-HT(1B)-like receptor activity of a novel series of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives are described. Modifications to the 5-ethylene-linked heterocycle and to substituents on the 2-benzylamide side chain have been explored. Several compounds were identified which exhibited affinity at the vascular 5-HT(1B)-like receptor of pK(B) > 7.0, up to 100-fold selectivity over alpha(1)-adrenoceptor affinity and 5-HT(2A) receptor affinity, and which exhibited a favorable pharmacokinetic profile. N-Benzyl-3-[2-(dimethylamino)ethyl]-5-[2-(4,4-dimethyl-2, 5-dioxo-1-imidazolidinyl)ethyl]-1H-indole-2-carboxamide (23) was identified as a highly potent, silent (as judged by the inability of angiotensin II to unmask 5-HT(1B)-like receptor-mediated agonist activity in the rabbit femoral artery), and competitive vascular 5-HT(1B)-like receptor antagonist with a plasma elimination half-life of approximately 4 h in dog plasma and with good oral bioavailability. The selectivity of compounds from this series for the vascular 5-HT(1B)-like receptors over other receptor subtypes is discussed as well as a proposed mode of binding to the receptor pharmacophore. It has been proposed that the aromatic ring of the 2, N-benzylcarboxamide group can occupy an aromatic binding site rather than the indole ring. The resulting conformation allows an amine-binding site to be occupied by the ethylamine nitrogen and a hydrogen-bonding site to be occupied by one of the hydantoin carbonyls. The electronic nature of the 2,N-benzylcarboxamide aromatic group as well as the size of substituents on this aromatic group is crucial for producing potent and selective antagonists. The structural requirement on the 3-ethylamine side chain incorporating the protonatable nitrogen is achieved by the bulky 2, N-benzylcarboxamide group and its close proximity to the 3-side chain.
机译:描述了一系列新的取代的2,N-苄基羧酰胺基-5-(2-乙基-1-二氧代咪唑啉基)-N,N-二甲基色胺衍生物的合成和血管5-HT(1B)样受体活性。已经研究了对5-乙烯-连接的杂环和2-苄基酰胺侧链上的取代基的修饰。鉴定出几种化合物,它们在pK(B)> 7.0的血管5-HT(1B)样受体上表现出亲和力,选择性比alpha(1)-肾上腺素受体亲和力和5-HT(2A)受体亲和力高100倍,并且表现出良好的药代动力学特征。 N-苄基-3- [2-(二甲基氨基)乙基] -5- [2-(4,4-二甲基-2,5-二氧-1-咪唑啉基)乙基] -1H-吲哚-2-羧酰胺(23)被鉴定为高度有效,沉默的(通过血管紧张素II无法掩盖兔股动脉中的5-HT(1B)样受体介导的激动剂活性来判断)和竞争性血管5-HT(1B)样受体拮抗剂在犬血浆中的血浆消除半衰期约为4小时,口服生物利用度良好。讨论了该系列化合物相对于其他受体亚型对血管5-HT(1B)-样受体的选择性,以及与受体药效团结合的提议模式。已经提出了2,N-苄基羧酰胺基团的芳环可以占据芳族结合位点而不是吲哚环。所得到的构象允许胺结合位点被乙胺氮占据并且氢键合位点被乙内酰脲羰基之一占据。 2,N-苄基羧酰胺芳族基团的电子性质以及该芳族基团上取代基的大小对于产生有效和选择性的拮抗剂至关重要。结合可质子化氮的3-乙胺侧链的结构要求是通过庞大的2,N-苄基羧酰胺基团及其与3-侧链的紧邻来实现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号